The ACME Laboratories Ltd. (DSE:ACMELAB)
Bangladesh · Delayed Price · Currency is BDT 79.30
+0.10 (0.13%)
At close: Sep 24, 2026
The ACME Laboratories Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 16,780 | 15,278 | 14,495 | 18,198 | 18,811 | 15,595 | |
Market Cap Growth | 2.59% | 5.40% | -20.35% | -3.26% | 20.62% | 16.25% |
Enterprise Value | 36,729 | 37,781 | 34,662 | 35,296 | 31,966 | 29,263 |
Last Close Price | 79.30 | 68.79 | 62.30 | 75.18 | 74.97 | 60.47 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 6.29 | 6.29 | 5.90 | 7.90 | 8.91 | 9.94 |
PS Ratio | 0.42 | 0.43 | 0.45 | 0.68 | 0.79 | 0.75 |
PB Ratio | 0.60 | 0.57 | 0.58 | 0.78 | 0.87 | 0.78 |
P/TBV Ratio | 0.60 | 0.57 | 0.58 | 0.78 | 0.87 | 0.78 |
P/FCF Ratio | 5.29 | 149.79 | - | - | - | 17.04 |
P/OCF Ratio | 2.93 | 4.80 | 7.41 | 14.46 | 16.56 | 5.79 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 0.92 | 1.05 | 1.09 | 1.31 | 1.34 | 1.41 |
EV/EBITDA Ratio | 4.10 | 4.47 | 4.80 | 6.00 | 5.96 | 5.89 |
EV/EBIT Ratio | 5.48 | 5.72 | 6.11 | 7.89 | 7.96 | 8.04 |
EV/FCF Ratio | 11.59 | 370.42 | - | - | - | 31.97 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.85 | 0.93 | 0.96 | 0.89 | 0.74 | 0.76 |
Debt / EBITDA Ratio | 2.65 | 2.94 | 3.30 | 3.52 | 2.96 | 3.06 |
Debt / FCF Ratio | 7.50 | 244.28 | - | - | - | 16.68 |
Net Debt / Equity Ratio | 0.71 | 0.86 | 0.89 | 0.83 | 0.68 | 0.67 |
Net Debt / EBITDA Ratio | 2.23 | 2.71 | 3.07 | 3.29 | 2.74 | 2.71 |
Net Debt / FCF Ratio | 6.29 | 224.26 | -10.26 | -4.83 | -23.88 | 14.74 |
Asset Turnover | 0.68 | 0.63 | 0.60 | 0.58 | 0.57 | 0.52 |
Inventory Turnover | 1.86 | 1.70 | 1.69 | 1.77 | 2.22 | 2.47 |
Quick Ratio | 0.34 | 0.26 | 0.24 | 0.22 | 0.23 | 0.30 |
Current Ratio | 1.20 | 1.15 | 1.11 | 1.12 | 1.12 | 1.14 |
Return on Equity (ROE) | 9.86% | 9.38% | 10.16% | 10.24% | 10.10% | 8.02% |
Return on Assets (ROA) | 7.10% | 7.24% | 6.69% | 5.99% | 6.02% | 5.69% |
Return on Invested Capital (ROIC) | 10.47% | 9.86% | 9.68% | 9.02% | 9.00% | 8.28% |
Return on Capital Employed (ROCE) | 17.80% | 18.20% | 16.60% | 14.20% | 14.60% | 13.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 15.89% | 15.90% | 16.95% | 12.66% | 11.22% | 10.06% |
FCF Yield | 18.89% | 0.67% | -14.92% | -21.99% | -3.27% | 5.87% |
Dividend Yield | 4.41% | 5.09% | 5.62% | 4.39% | 4.00% | 4.13% |
Payout Ratio | 27.80% | 30.50% | 28.54% | 27.46% | 25.20% | 33.68% |
Total Shareholder Return | 4.41% | 5.09% | 5.62% | 4.39% | 4.00% | 4.13% |